Vornorexant (TS-142) — Research Compounds Library | RetatrutideCompare
Dual orexin-receptor antagonist (DORA) developed by Taisho. Phase 2 RCT in insomnia disorder showed improvements in sleep onset and maintenance with favorable next-day function.
Dual orexin-receptor antagonist (DORA) developed by Taisho. Phase 2 RCT in insomnia disorder showed improvements in sleep onset and maintenance with favorable next-day function.